Abstract
The number of biomarker candidates is often much larger than the number of clinical patient data points available, which motivates the use of a rational candidate variable filtering methodology. The goal of this paper is to apply such a bioinformatics filtering process to isolate a modest number (<10) of key interacting genes and their associated single nucleotide polymorphisms involved in radiation response, and to ultimately serve as a basis for using clinical datasets to identify new biomarkers. In step 1, we surveyed the literature on genetic and protein correlates to radiation response, in vivo or in vitro, across cellular, animal, and human studies. In step 2, we analyzed two publicly available microarray datasets and identified genes in which mRNA expression changed in response to radiation. Combining results from Step 1 and Step 2, we identified 20 genes that were common to all three sources. As a final step, a curated database of protein interactions was used to generate the most statistically reliable protein interaction network among any subset of the 20 genes resulting from Steps 1 and 2, resulting in identification of a small, tightly interacting network with 7 out of 20 input genes. We further ranked the genes in terms of likely importance, based on their location within the network using a graph-based scoring function. The resulting core interacting network provides an attractive set of genes likely to be important to radiation response.
Introduction
In the ‘omics’ era, the number of biomarker candidates potentially available for statistical testing is often much larger than the number of patient data points. This presents a fundamental problem in biomarker research: the number of candidate genetic or epigenetic markers often overwhelms the inherent statistical power available in a clinical dataset, which usually has tens or hundreds of patient cases available rather than thousands. This statistical mismatch is typically becoming worse as more of the intracellular complexity of molecular machinery is identified. At one extreme, a genome-wide association study (GWAS) examining the correlations of millions of tag single-nucleotide polymorphisms (SNPs) to cancer treatment outcome may require a very high, and biologically unlikely, odds ratio given the number of multiple comparisons, to reach statistical significance. At the other extreme, it is clear that investigators cannot a priori identify the most important biomarker genes or SNPs for testing. These unsatisfying extreme cases motivated our search for a middle strategy that would objectively identify a modest number of promising SNPs/proteins, etc. as a cohort for testing against a given dataset. Because clinical datasets for a given endpoint are commonly of modest size (tens or hundreds, not thousands, of patients), we searched for key protein interaction networks that result in less than approximately a hundred candidate SNPs. Our methodology, of course, could be adopted to throw a wider net if much larger datasets become available. Our endpoint of interest is late toxicity following radiation therapy for cancer. Many cancer patients who receive radiation therapy suffer from acute or late side effects; the risk for experiencing these side effects is expected to have a genetic component [1]. Numerous genes participate in a cascade of events in response to radiation and the resulting DNA damage in a complex signal transduction network [2].
Recently, many studies have focused on finding radio-responsive genes at the whole genome level with gene expression microarrays. Rieger and Chu used oligonucleotide microarrays to develop a genome-wide portrait of transcriptional response to ionizing radiation (IR) and ultraviolet (UV) radiation in cell lines collected from 15 healthy individuals [3]. In another study [1] using samples extracted from cancer patients with acute radiation toxicity, Rieger et al. showed that toxicity after radiation therapy (radiotherapy) could be associated with abnormal transcriptional responses to DNA. Jen and Cheung [2] assessed transcriptional levels of genes in lymphoblastoid cells at various time points with 3 Gy and 10 Gy of ex vivo IR exposure. Following 10 Gy of IR exposure, more genes were induced, suggesting that a higher radiation dose causes a more complex response. A high percentage of significant genes were involved in cell cycle, cell death, DNA repair, DNA metabolism, and RNA processing. Eschrich et al. [4] analyzed microarray gene expression data derived from 48 human cancer cell lines and generated an interaction network using MetaCore software (GeneGo, Encinitas, CA) with the top 500 genes identified by linear regression analysis. Subsequently, based on 10 hub genes obtained from the network, they modeled radiosensitivity (survival fraction at 2 Gy) using a linear regression method.
Normal tissue toxicity after radiotherapy may partially be attributable to specific genetic mutations. In an effort to identify candidate polymorphisms at the SNP level involved in the cellular response to irradiation in breast and prostate cancers, Popanda et al. [5] surveyed many published studies that show associations of SNPs in candidate genes with acute or late side effects of radiotherapy. Andreassen and Alsner [6] summarized studies published on genetic variation in normal tissue toxicity and proposed a model of allelic architecture that illustrates relative risk for genetic variants associated with normal tissue radiosensitivity.
In this study, we attempted to define an objective method for identifying key radiosensitivity genes likely to have a significant impact on clinical outcome following radiotherapy. We elected to construct a staged filter. The first step was a comprehensive literature review of radiosensitivity-related genes. These genes were then further delimited to genes responding to IR in an analysis of publicly available microarray gene expression datasets. We further focused the search on interacting networks, based on the hypothesis that good biomarkers are likely to be embedded in important pathways or networks involving multiple genes known to be important to the endpoint in question [7]. This last step may potentially add new, previously unreported targets, based on curated pathway libraries.
Materials and Methods
In summary, we used a multi-component filtering process: (1) genes associated with radiation response in the literature and (2) genes associated with radiation response in two microarray mRNA datasets. Overlapping genes from these three sources were fed into a curated protein interaction network system (MetaCore) to identify key interacting networks. The most important network was taken as our target set.
Literature Review of Radiosensitivity-related Genes
We attempted a complete literature review of all genes implicated in radiation response. Published papers were searched by using PubMed and Scopus search engines in 2010 and by following citations within the identified papers. The search strategy was based on a combination of the following search keywords: “SNPs, polymorphisms, or microsatellites” and “irradiation, radiation, or radiotherapy” and “morbidity, radiosensitivity, normal tissue, toxicity, or complications” and “siRNA, knockdown, or knockout”. Papers referred to in the original search returns, or referring to the original papers at a later date were also reviewed. This resulted in an in-depth review of around 200 published papers, and a list of 221 genes implicated in radiation response.
Microarray Gene Expression Datasets
To identify significant radio-responsive genes based on microarray gene expression profiling, we searched for all relevant, publically available microarray datasets, resulting in locating two datasets. We analyzed GSE1977 and GSE23393, downloaded from the publicly available Gene Expression Omnibus (GEO) database (http://www.ncbi.nlm.nih.gov/geo/). In GSE1977, lymphoblastoid cell lines obtained from 15 healthy individuals were established by immortalization of peripheral blood B-lymphocytes [3]. The response of numerous genes was measured by mock treatment, UV, and X-ray exposures. Cells were exposed to 5 Gy radiation doses and harvested for RNA 4 hours later. In our work, the differential between mock and X-ray cases was used. In contrast, in GSE23393 [8], blood was gathered from eight radiotherapy patients (at our institution): eight samples were collected immediately before irradiation and another eight samples were collected at 4 hours after total body irradiation with 1.25 Gy X-rays.
Preprocessing for Identification of Significant Genes
Before the microarray datasets were analyzed, gene expression values were log-base-2 transformed, followed by quantile normalization across all samples [9]. Microarray gene expression values from two different conditions (before and after exposure) were compared using a two-tailed t-test to identify differentially expressed genes (radio-responsive genes). To estimate the likelihood of identifying significant genes by chance, we computed permutation-based p-values using 10,000 permutations. Then, using Storey’s method, the false discovery rate (FDR) and q-value for each gene were calculated [10]. Significance Analysis of Microarrays (SAM) and t-test are widely used for indentifying differentially expressed genes in the analysis of microarray data [11]. We chose a permutation t-test with an assumption that the permutation t-test and SAM could yield a set of similar significant genes, as recommended by Chen et al. [11]. In this analysis, we did not use a fold change cutoff in order to avoid losing some important genes, a problem described by Larsson et al. [12].
Pathway and Process Analysis
Significant genes were identified both in the literature review and the analysis of two microarray datasets (GSE1977 and GSE23393). These genes were then entered into a manually curated pathway analysis database (MetaCore™, GeneGo, Inc., Carlsbad, California). The commercial pathway analysis system, MetaCore, computes p-values for overrepresented pathways and processes. MetaCore is based on a comprehensive manually curated attempt to capture protein interactions as networks. We used MetaCore to attempt to find the most probable interaction pathways among a set of genes uploaded by the user. Several algorithms are available to do this; we used the “Analyze network” option. If necessary, MetaCore adds appropriate genes to complete a network.
Gene Ontology Analysis
A further analysis of the resulting significant genes was performed using the Gene Ontology (GO) database (www.geneontology.org), in which genes are annotated with known molecular functions, biological processes, and cellular component locations.
Gene Ranking
In our previous work to identify blood-based protein biomarkers to predict radiation-induced pneumonitis [7], we proposed a graph-based scoring function to rank proteins in a protein–protein interaction network. The network consisted of candidate proteins we identified in mass spectrometry analysis and four previously identified (‘regularization’) biomarker proteins. Using the proposed method, we attempted to measure a ‘functional distance’ between each candidate protein and the four regularization proteins, based on the hypothesis that some proteins relevant to a specific disease exist in close proximity, in a network sense. In the current study, we modified that algorithm such that within a given protein–protein interaction network for a biological process, we estimate the functional distance between each protein and all the remaining proteins in the network, since all the proteins in the network are more likely to be related to one another and act together in the biological process.
To rank biomarkers, we modelled each protein–protein interaction network as a directed graph, G = (V, E), where V consists of a set of nodes (proteins) and E is the set of possible edges (protein–protein interactions) between pairs of nodes. Let A and B be two proteins in a network. We assume that there are two concepts of distance between A and B: a geometrical distance that is defined in terms of the number of nodes in the shortest path between A and B, as well as a virtual distance that is defined in terms of the number of publications that verify the interactions along the shortest path. Intuitively, as the number of intermediate nodes between A and B increases, the geometrical distance increases and the two proteins are less likely to be correlated. In contrast, considering virtual distance, we expect that as the number of references demonstrating a relationship between two proteins increases, they are more likely to be related. In other words, the number of references is proportional to relatedness while the number of nodes is inversely proportional.
Using a power law, we calculate two scores from A to B: a reference score (rs) and a node score (ns) as follows:
(1) |
(2) |
where r and n are the total number of references and nodes in the shortest path from A to B. We suppose that the influence of the number of nodes is greater than that of the number of references. Therefore, as the number of intermediate nodes between any two given nodes increases, the relationship between the two nodes becomes much less likely. The score capturing the path from A to B is defined as the summation of two different scores:
(3) |
Likewise, we also estimate a score from B to A, Then, the final score, between A and B, is defined as the maximal value among and :
(4) |
We suppose that the final score of a protein is computed by the summation of all scores between the protein and all the remaining proteins in the network. Hence, the final score of a protein A is defined by:
(5) |
To estimate the number of references and nodes, we employed two methods. For the number of references, we used a function in the MetaCore software that provides the number of references between two connected proteins in a network. For the number of nodes, we used the Floyd-Warshall algorithm that was originally designed to find the shortest paths between all pairs of nodes based on dynamic programming [13]. To apply this algorithm to our problem of estimating the number of nodes, we modified the original Floyd-Warshall algorithm such that an equal weight of 1 was assigned to all connected edges in a network. As a result, the modified algorithm generated a matrix that represents the number of nodes on the all-pairs shortest-paths in a given protein–protein interaction network.
Results
Identification of Significant Biomarkers via Literature Review
Based on the literature review, several types of biomarkers, including genes, proteins, kinases, ligands, and protein complexes were identified. To unify the biomarker terms differently used across studies, we converted all the biomarkers into their corresponding gene symbols. As a result, 221 unique genes and 4 protein complexes (DNA-PK, HSP70, MRN(95), RAS) were identified from around 200 papers that studied radiation response-related biomarkers [4], [14]–[185]. Table 1 displays the 221 unique genes and their corresponding GO processes, including DNA repair, cell proliferation/cycle, apoptosis, RNA processing, and response to stress. It is well known that ionizing radiation causes DNA damage that activates the p53 pathway through ATM [186]. Genes that are involved in cell cycle, such as CDKN1A, GADD45A, MDM2, and CCNG1, are known to be dependent on p53 [2]. Also, other cell cycle-related genes including CCNB1 and CDC20 were identified. Among cell cycle or proliferation genes, TOB1, BTG2, and CDKN1A are anti-proliferative/check-point related [3]. Several genes (XPC, DDB2, PCNA, ERCC4, and NBN) are involved in DNA repair. Two major pathways to repair IR-induced DNA double-strand breaks are homologous recombination (HR; genes include XRCC2, XRCC3, MRE11A, RAD50, NBN, BRCA1, and BRCA2) and non-homologous end joining (NHEJ; genes include LIG4, XRCC4, XRCC5, XRCC6, and DNA-PK) [3]. Some genes, including FAS, BBC3, and TNF, are involved in apoptosis [187]. BCL2 and DDR1 are anti-apoptotic.
Table 1. Radio-responsive biomarkers identified by literature review and their biological processes.
Gene Symbol | Entrez Gene ID | DNA repair | Cell proliferation | Cell cycle | Apoptosis | Response to stress | Reference | ||
ABCA1 | 19 | [14] | |||||||
ABL1 | 25 | v | v | v | v | [4] | |||
ACTA2 | 59 | [15] | |||||||
AEN | 64782 | v | v | [16] | |||||
AKR1B1 | 231 | v | [17] | ||||||
AKT1 | 207 | v | v | v | [18] | ||||
ALAD | 210 | [19], [20] | |||||||
ANXA1 | 301 | v | v | v | v | [21] | |||
APEX1 | 328 | v | v | [22]–[26] | |||||
APOE | 348 | v | v | v | [27] | ||||
AR | 367 | v | [4] | ||||||
ATF3 | 467 | v | [28] | ||||||
ATM | 472 | v | v | v | v | v | [25], [26], [29]–[43] | ||
BAD | 572 | v | v | [44] | |||||
BAK1 | 578 | v | [45] | ||||||
BAX | 581 | v | [37], [44]–[47] | ||||||
BAZ1B | 9031 | v | v | [17] | |||||
BBC3 | 27113 | v | [16], [48]–[50] | ||||||
BCL2 | 596 | v | v | v | v | [37], [44], [46], [51], [52] | |||
BCL2L1 | 598 | v | v | v | [51] | ||||
BIRC5 | 332 | v | v | [53] | |||||
BRCA1 | 672 | v | v | v | v | v | [54]–[59] | ||
BRCA2 | 675 | v | v | v | v | v | [54]–[57], [59], [60] | ||
BTG2 | 7832 | v | v | v | v | [61] | |||
CAT | 847 | v | v | [62] | |||||
CAV1 | 857 | v | v | [63] | |||||
CCNB1 | 891 | v | v | v | [48] | ||||
CCND1 | 595 | v | v | v | [46] | ||||
CCNE1 | 898 | v | [61] | ||||||
CCNG1 | 900 | v | v | v | [49] | ||||
CD24 | 100133941 | v | v | v | [21] | ||||
CD40 | 958 | v | v | [64] | |||||
CD68 | 968 | [20] | |||||||
CD69 | 969 | [16] | |||||||
CD70 | 970 | v | v | [65] | |||||
CD83 | 9308 | v | [21] | ||||||
CDC20 | 991 | v | v | [66] | |||||
CDC6 | 990 | v | v | [61] | |||||
CDH2 | 1000 | [21] | |||||||
CDK1 | 983 | v | v | v | v | [4], [61] | |||
CDK2 | 1017 | v | v | [61] | |||||
CDKN1A | 1026 | v | v | v | v | [15], [16], [37], [47]–[50], [61], [67], [68] | |||
CDKN2A | 1029 | v | v | v | v | [69] | |||
CHEK1 | 1111 | v | v | v | v | [70], [71] | |||
CLIC1 | 1192 | [72] | |||||||
CRYAB | 1410 | v | v | [21] | |||||
CSNK2A2 | 1459 | v | [73] | ||||||
CXCR4 | 7852 | v | v | [15] | |||||
CYP2D6 | 1565 | [74] | |||||||
DCN | 1634 | v | [21] | ||||||
DDB2 | 1643 | v | v | [15], [21] | |||||
DDR1 | 780 | [15] | |||||||
DDR2 | 4921 | v | [15] | ||||||
DDX17 | 10521 | [17] | |||||||
DRAP1 | 10589 | [17] | |||||||
DUSP8 | 1850 | [16] | |||||||
EGFR | 1956 | v | v | v | v | [46] | |||
EGR1 | 1958 | v | [16] | ||||||
EGR4 | 1961 | v | [16] | ||||||
EI24 | 9538 | v | [47] | ||||||
EIF2AK3 | 9451 | v | v | [75] | |||||
EPDR1 | 54749 | [20] | |||||||
ERBB2 | 2064 | v | v | v | [46], [76]–[78] | ||||
ERCC1 | 2067 | v | v | [52] | |||||
ERCC2 | 2068 | v | v | v | v | v | [36], [74] | ||
ERCC4 | 2072 | v | v | v | [52], [79] | ||||
ERCC5 | 2073 | v | v | v | [52] | ||||
FAS | 355 | v | [47], [80] | ||||||
FASLG | 356 | v | v | v | [80] | ||||
FDXR | 2232 | [49], [50], [68] | |||||||
FGF1 | 2246 | v | v | [81] | |||||
FGF2 | 2247 | v | v | v | v | [81] | |||
GADD45A | 1647 | v | v | v | v | [15], [16], [48], [49], [61], [67] | |||
GBP1 | 2633 | [21] | |||||||
GDF15 | 9518 | [15], [82] | |||||||
GFER | 2671 | v | [83] | ||||||
GRAP | 10750 | [16] | |||||||
GSTA1 | 2938 | [62] | |||||||
GSTM1 | 2944 | [62], [84] | |||||||
GSTP1 | 2950 | v | [36], [62], [85], [86] | ||||||
GSTT1 | 2952 | [62], [84] | |||||||
H2AFX | 3014 | v | v | v | [41], [87], [88] | ||||
HDAC1 | 3065 | v | v | v | [4], [89] | ||||
HERC2 | 8924 | v | v | v | [90] | ||||
HSP90AB1 | 3326 | v | [91] | ||||||
HSP90B1 | 7184 | v | v | [82] | |||||
HSPB1 | 3315 | v | v | [91], [92] | |||||
HUS1 | 3364 | v | v | v | [93] | ||||
ICAM2 | 3384 | [94] | |||||||
ID3 | 3399 | v | v | v | [20] | ||||
IER5 | 51278 | [95] | |||||||
IFNG | 3458 | v | v | v | v | [16] | |||
IGF1R | 3480 | v | v | [46], [96] | |||||
IGFBP3 | 3486 | v | v | [21] | |||||
IL12RB2 | 3595 | v | [14] | ||||||
IL17A | 3605 | v | v | [97] | |||||
ILK | 3611 | v | v | v | [98] | ||||
IRF1 | 3659 | [4] | |||||||
JUN | 3725 | v | v | v | v | [4], [16] | |||
KRAS | 3845 | [99] | |||||||
LIG1 | 3978 | v | v | v | [20] | ||||
LIG3 | 3980 | v | v | v | [19], [20] | ||||
LIG4 | 3981 | v | v | v | v | v | [35], [60], [74], [100] | ||
LOX | 4015 | v | [21] | ||||||
LSM7 | 51690 | [17] | |||||||
MAD2L2 | 10459 | v | [19] | ||||||
MAP3K7 | 6885 | v | v | [19], [20] | |||||
MC1R | 4157 | v | v | v | [101] | ||||
MCL1 | 4170 | v | [102] | ||||||
MCM2 | 4171 | v | [61] | ||||||
MDC1 | 9656 | v | v | v | [35] | ||||
MDM2 | 4193 | v | v | v | [16], [49], [52], [103] | ||||
MGMT | 4255 | v | v | v | [20] | ||||
MLH1 | 4292 | v | v | v | v | [46], [74] | |||
MMP2 | 4313 | v | [104] | ||||||
MMP9 | 4318 | v | [105] | ||||||
MPO | 4353 | v | v | [62], [106] | |||||
MR1 | 3140 | [15] | |||||||
MRE11A | 4361 | v | v | v | [29] | ||||
MRPL23 | 6150 | [17] | |||||||
MSH2 | 4436 | v | v | v | v | [46] | |||
MTHFR | 4524 | [107] | |||||||
MTOR | 2475 | v | v | [45] | |||||
MYC | 4609 | v | v | v | [108] | ||||
NBN | 4683 | v | v | v | v | [29], [109] | |||
NEIL1 | 79661 | v | v | [110] | |||||
NEK2 | 4751 | v | [111] | ||||||
NFKB1 | 4790 | v | v | [112] | |||||
NNMT | 4837 | [91] | |||||||
NONO | 4841 | v | v | [113] | |||||
NOS3 | 4846 | v | v | v | [62], [106] | ||||
NOX4 | 50507 | v | v | [114] | |||||
NUDT1 | 4521 | v | v | [17] | |||||
OGG1 | 4968 | v | v | [115] | |||||
PAH | 5053 | [20] | |||||||
PAK6 | 56924 | [116] | |||||||
PARP1 | 142 | v | v | [70], [117] | |||||
PCNA | 5111 | v | v | v | [16], [118] | ||||
PER3 | 8863 | [20] | |||||||
PHLPP2 | 23035 | [119] | |||||||
PHPT1 | 29085 | [50] | |||||||
PIK3CA | 5290 | v | [120] | ||||||
PIM2 | 11040 | v | v | v | [52] | ||||
PLK2 | 10769 | v | [16] | ||||||
PLK3 | 1263 | [61] | |||||||
PMS2 | 5395 | v | v | v | [46] | ||||
POLB | 5423 | v | v | v | [121] | ||||
POLQ | 10721 | v | v | [60] | |||||
PPA1 | 5464 | [111], [119] | |||||||
PPM1D | 8493 | v | v | [15], [122] | |||||
PRDX1 | 5052 | v | v | v | [116] | ||||
PRDX4 | 10549 | [123] | |||||||
PRKCB | 5579 | v | [4] | ||||||
PRKCZ | 5590 | v | v | [52] | |||||
PRKDC | 5591 | v | v | v | [124]–[126] | ||||
PROCR | 10544 | v | [21] | ||||||
PROM1 | 8842 | [127] | |||||||
PSMB4 | 5692 | v | v | [17] | |||||
PSMD1 | 5707 | v | [17] | ||||||
PTCH1 | 5727 | v | [128] | ||||||
PTEN | 5728 | v | v | v | [129] | ||||
PTGS2 | 5743 | v | v | v | v | [46] | |||
PTTG1 | 9232 | v | v | v | [19], [130] | ||||
RAD21 | 5885 | v | v | v | v | [30], [31], [43], [131] | |||
RAD23B | 5887 | v | v | [17] | |||||
RAD50 | 10111 | v | v | v | [29], [132] | ||||
RAD51 | 5888 | v | v | v | [133] | ||||
RAD54L | 8438 | v | v | v | [134] | ||||
RAD9A | 5883 | v | v | v | v | [19], [52] | |||
RALBP1 | 10928 | [135], [136] | |||||||
RELA | 5970 | v | v | v | [4], [112] | ||||
RND1 | 27289 | [16] | |||||||
RRM2 | 6241 | [137] | |||||||
RRM2B | 50484 | v | v | v | [138] | ||||
S100A11 | 6282 | v | [15] | ||||||
SAG | 6295 | [139] | |||||||
SART1 | 9092 | v | v | [20] | |||||
SEC22B | 9554 | [17] | |||||||
SEPHS1 | 22929 | [140] | |||||||
SERPINA3 | 12 | v | [20] | ||||||
SERPINE1 | 5054 | v | v | v | [141] | ||||
SESN1 | 27244 | v | v | v | [49], [50] | ||||
SIRT1 | 23411 | v | v | v | v | [142] | |||
SMPD1 | 6609 | v | [81] | ||||||
SOD1 | 6647 | v | v | v | [143] | ||||
SOD2 | 6648 | v | v | v | [25], [26], [30], [31], [36], [62], [144], [145] | ||||
SRC | 6714 | [146] | |||||||
SRF | 6722 | v | [17] | ||||||
STAT1 | 6772 | v | v | v | [4], [147] | ||||
STAT3 | 6774 | v | [148], [149] | ||||||
SUMO1 | 7341 | v | v | [4] | |||||
TGFB1 | 7040 | v | v | v | v | [25], [26], [30], [36], [43], [145], [150]–[154] | |||
TNF | 7124 | v | v | v | v | [155] | |||
TNFRSF10B | 8795 | v | [47] | ||||||
TNFRSF1A | 7132 | v | v | [112] | |||||
TNFSF10 | 8743 | v | [156] | ||||||
TNFSF9 | 8744 | v | v | [16] | |||||
TOB1 | 10140 | v | [157] | ||||||
TOP2A | 7153 | v | v | v | [158] | ||||
TOR1AIP1 | 26092 | [16] | |||||||
TP53 | 7157 | v | v | v | v | v | [37], [41], [46], [48] | ||
TP63 | 8626 | v | v | v | v | [159] | |||
TPP2 | 7174 | [160] | |||||||
TRAF2 | 7186 | v | v | [161] | |||||
TRAF4 | 9618 | v | v | [16] | |||||
TXN | 7295 | v | [162] | ||||||
TXNRD1 | 7296 | v | [163] | ||||||
UBB | 7314 | v | v | [17] | |||||
UHRF1 | 29128 | v | v | v | v | [164] | |||
UIMC1 | 51720 | v | v | v | [165] | ||||
VEGFA | 7422 | v | v | v | [46], [166] | ||||
WRN | 7486 | v | v | v | [110] | ||||
WT1 | 7490 | v | v | [167] | |||||
XIAP | 331 | v | v | [49], [168], [169] | |||||
XPC | 7508 | v | v | v | [124], [170] | ||||
XRCC1 | 7515 | v | v | [22,23,25,26,30,31,36,43,115, | |||||
144,145,150,154,171–175] | |||||||||
XRCC2 | 7516 | v | v | v | v | [109] | |||
XRCC3 | 7517 | v | v | [25,26,30,31,74,109,115,134, | |||||
144,145,172,174–176] | |||||||||
XRCC4 | 7518 | v | v | v | v | [164] | |||
XRCC5 | 7520 | v | v | v | v | [52], [60], [172], [177]–[179] | |||
XRCC6 | 2547 | v | v | [20], [176], [178], [180], [181] | |||||
DNA-PK | [52], [182] | ||||||||
HSP70 | [183] | ||||||||
MRN(95) | [184] | ||||||||
RAS | [185] |
For biological process and pathway analysis, the 221 unique genes were uploaded into the MetaCore. Figure 1 illustrates a direct interaction network generated with these genes. As shown, numerous genes are strongly connected to one another, suggesting that interacting genes are more likely to play related roles. Table 2 shows the top ten GeneGo pathways, GeneGo processes, and GO processes. As can be seen in the table, the most highly ranked pathways and processes are associated with DNA damage and repair, cell cycle, and apoptosis.
Table 2. The top ten GeneGo pathways/processes and GO processes resulting from genes identified via literature review.
Ranking | GeneGo Pathways |
1 | DNA damage_Role of Brca1 and Brca2 in DNA repair |
2 | DNA damage_ATM/ATR regulation of G1/S checkpoint |
3 | DNA damage_NHEJ mechanisms of DSBs repair |
4 | DNA damage_Brca1 as a transcription regulator |
5 | Signal transduction_AKT signaling |
6 | Some pathways of EMT in cancer cells |
7 | Apoptosis and survival_Ceramides signaling pathway |
8 | Signal transduction_PTEN pathway |
9 | Transcription_P53 signaling pathway |
10 | DNA damage_ATM/ATR regulation of G2/M checkpoint |
Ranking | GeneGo Processes |
1 | DNA damage_Checkpoint |
2 | DNA damage_DBS repair |
3 | Cell cycle_G1-S Growth factor regulation |
4 | DNA damage_BER-NER repair |
5 | Cell cycle_Meiosis |
6 | DNA damage_Core |
7 | Apoptosis_Apoptotic nucleus |
8 | Cell cycle_G1-S Interleukin regulation |
9 | Development_EMT_Regulation of epithelial-to-mesenchymal transition |
10 | Cell cycle_S phase |
Ranking | GO Processes |
1 | Cellular response to stimulus |
2 | Cellular response to stress |
3 | Response to stress |
4 | Regulation of programmed cell death |
5 | Regulation of cell death |
6 | Regulation of apoptosis |
7 | Response to DNA damage stimulus |
8 | Response to stimulus |
9 | DNA repair |
10 | Response to organic substance |
Identification of Significant Genes via Microarray Dataset Analysis
To identify significant changes in gene expression values between the two groups (before and after irradiation) in two microarray datasets, a t-test with 10,000 permutations was performed. To estimate p-values, we counted the number of permutations for each gene whose t-scores are greater than or equal to the t-score calculated with observed values. Then, the number of permutations passed the criterion was divided by the total number of permutations [188]. With an FDR of 20%, 631 probes (corresponding to 550 unique genes) were significantly identified for GSE1977. Figure 2 shows a normal quantile plot of t-scores for GSE1977. Data points of genes that are farther away from the black diagonal line are considered to be differentially expressed. Figure 3 displays a volcano plot that depicts the –log10 of q-values against log2 of fold changes for all genes. The majority of genes with an FDR of 20% changed 1.2-fold or higher. For GSE23393, with an FDR of 20%, 224 probes (corresponding to 184 unique genes) were identified (Figure S1 and Figure S2).
Overlapping Genes
To delimit our potential biomarker set, we investigated which genes are commonly or uniquely found among the set of genes identified by our literature review and two sets of genes identified in the analysis of the two gene microarray datasets, as summarized in Figure 4 . The rationale is that those are genes likely to be key to an active response, but unlikely to be false positives due to the literature review. Twenty genes were commonly identified among the three different analyses (literature review and two microarray datasets), as shown in Table 3 . We further analyzed pathways and biological processes associated with the 20 genes. Table 4 shows the top ten GeneGo pathways generated by the MetaCore software (Table S1). Not surprisingly, even with the 20 genes, DNA damage/repair and apoptosis-related pathways were highly ranked.
Table 3. Twenty genes commonly identified by literature review and analysis of two microarray datasets.
Gene Symbol | Entrez ID | Gene Name |
ACTA2 | 59 | actin, alpha 2, smooth muscle, aorta |
BAX | 581 | BCL2-associated X protein |
BBC3 | 27113 | BCL2 binding component 3 |
BTG2 | 7832 | BTG family, member 2 |
CCNG1 | 900 | cyclin G1 |
CD70 | 970 | CD70 molecule |
CDKN1A | 1026 | cyclin-dependent kinase inhibitor 1A (p21, Cip1) |
DDB2 | 1643 | damage-specific DNA binding protein 2, 48 kDa |
EI24 | 9538 | etoposide induced 2.4 mRNA |
FDXR | 2232 | ferredoxin reductase |
GADD45A | 1647 | growth arrest and DNA-damage-inducible, alpha |
MDM2 | 4193 | Mdm2 p53 binding protein homolog (mouse) |
MR1 | 3140 | major histocompatibility complex, class I-related |
MYC | 4609 | v-myc myelocytomatosis viral oncogene homolog (avian) |
PCNA | 5111 | proliferating cell nuclear antigen |
PLK2 | 10769 | polo-like kinase 2 |
PLK3 | 1263 | polo-like kinase 3 |
PPM1D | 8493 | protein phosphatase, Mg2+/Mn2+ dependent, 1D |
TNFRSF10B | 8795 | tumor necrosis factor receptor superfamily, member 10b |
XPC | 7508 | xeroderma pigmentosum, complementation group C |
Table 4. The top ten GeneGo pathways generated by MetaCore when the 20 overlapping genes were used.
# | GeneGo Pathways |
1 | DNA damage_Brca1 as a transcription regulator |
2 | DNA damage_ATM/ATR regulation of G1/S checkpoint |
3 | Signal transduction_AKT signaling |
4 | Apoptosis and survival_Apoptotic TNF-family pathway |
5 | DNA damage_ATM/ATR regulation of G2/M checkpoint |
6 | Apoptosis and survival_p53-dependent apoptosis |
7 | DNA damage_Role of Brca1 and Brca2 in DNA repair |
8 | DNA damage_Nucleotide excision repair |
9 | Transcription_P53 signaling pathway |
10 | Cytoskeleton remodeling_TGF, WNT and cytoskeletal remodeling |
Gene Ranking and Identification of a Core Radio-response Network
Figure 5 shows the most probable/robust single interaction network when the 20 overlapping genes were entered into the MetaCore software. Of the 20 input genes, seven genes appeared in this core radio-response network. We applied our graph-based scoring function to this network and the results are summarized in Table 5 . MYC was ranked first with a score of 113.74, which had a high p-value in GSE23393 and a statistically significant p-value, yet still relatively high compared to other genes, in GSE1977. As a hub gene, MYC had the highest number of edges (n = 12) that seem to contribute to the score. Overall p-values in GSE23393 (in situ IR) are higher than those of GSE1977 (ex vivo IR). Intuitively, as the number of edges increases, the score seems to increase. However, it should be noted that although GADD45A has 9 edges, it obtained a higher score than PPM1D, which has 11 edges. This is attributed to the fact that when we calculate the score for a gene, our scoring function takes into account all network interactions and the number of references on the interactions in the network. Interestingly, CDKN1A obtained a relatively high score of 100.13, considering only 3 edges and substantially low p-values (0.00027 in GSE1977 and 0.00367 in GSE23393).
Table 5. The results of the proposed scoring function test applied to the network in Figure 5 .
Ranking | Protein | Gene symbol | Score | GSE1977 p-value | GSE23393 p-value | No. of edges | ||
1 | c-Myc | MYC | 113.74 | 0.02420 | 0.14898 | 12 | ||
2 | GADD45 alpha | GADD45A | 110.34 | 8.63E-06 | 0.00172 | 9 | ||
3 | WIP1 | PPM1D | 108.16 | 0.00044 | 0.00310 | 11 | ||
4 | PUMA | BBC3 | 102.70 | 0.07171 | 0.01019 | 6 | ||
5 | p21 | CDKN1A | 100.13 | 0.00027 | 0.00367 | 3 | ||
6 | PLK3 (CNK) | PLK3 | 99.70 | 0.00285 | 0.08072 | 4 | ||
7 | XPC | XPC | 85.62 | 0.00068 | 0.03330 | 2 |
Discussion
We have demonstrated an unbiased bioinformatics filtering methodology to objectively identify a core network of key interacting genes that are important to radiation response. We hypothesized that, by combining several different types of datasets, we are increasingly likely to identify interacting genes that are particularly important to radiation response. We also hypothesize that these genes are therefore attractive candidates for biomarker testing. For example, the 7 key genes contain 89 relevant SNPs in our radiation therapy cancer dataset and we are in the process of testing late toxicity with the dataset. We make no claim that the network shown in Figure 5 dominates radiation response and do not expect that to be the case. Nevertheless, this network seems to be highly relevant to radiation response: among the 7 genes, 5 and 4 genes are involved in cell cycle control and apoptosis, respectively. More detailed information is shown in Table S2. Five of these genes, including MYC, BBC3, GADD45A, CDKN1A, and XPC belong to a list of 34 radio-responsive genes observed by Tusher et al. [187]. Moreover, this network is consistent with (though slightly different from) the programmed cell death network reported by Moussay et al. [189].
Figure 4 shows the number of genes commonly or uniquely identified among three different studies (literature review and analysis of two microarray datasets). Interestingly, relatively few genes overlapped among the three analyses. Literature coverage is expected to be incomplete regarding coverage of radiosensitivity genes. Microarray analysis is subject to high false positive and false negative rates [190]. Another possible reason for the small number of overlapped genes is the widely differing irradiation conditions and doses. Despite this, the biological processes and pathways generated from the 20 overlapping genes were similar to those generated from the whole literature review.
We further analyzed the 20 genes, uploading these genes into the MetaCore software. In the network of the most probable biological process shown in Figure 5 , only seven out of 20 genes appeared in the network. Additional genes were automatically added to the network by MetaCore, including AKT1, RELA, BCL2L1, PTEN, CDK1, and XIAP. Note, however, that these genes were also members of the list generated by our radiation response literature review, suggesting some consistency between these sources. This also suggests a potential ability to find novel biomarker candidates through the network mapping/ranking process, though that did not occur in this case.
The graph-based scoring function proposed in our previous study [7] was modified and applied to the network shown in Figure 5 . In some studies, researchers tend to regard genes with high degrees of connectivity (hub genes) as significant in an interaction network, while neglecting others [4]. While this is rational, finding hub genes based on edge connectivity considers only direct interactions between genes whereas our proposed approach takes into account all interactions in a network (that is, the entire graph structure) and the number of published references on the interactions. To measure the closeness between two proteins (say A and B), we employed two scores; a node score and a reference score. In a protein interaction network, it is obvious that as the number of internal nodes between A and B increases, these two proteins are less likely to be related with each other. In contrast, the reference score is a score calculated using the number of papers that studied on an interaction between two proteins, which can be important evidence that there is an actual relationship between the two proteins. As can be seen in Table S3, MYC was first ranked using a total score. However, BBC3 and PPM1D were first ranked using a reference score and a node score, respectively. CDKN1A, PLK3, and XPC obtained somewhat high scores considering their connectivity, suggesting that they could play important roles in this core network. We believe that the use of both scores could be more effective for ranking proteins in a protein interaction network.
Future work will test SNPs identified in this network against toxicity resulting from radiation therapy. As the number of patients available for SNP analyses increases, it may be rational to expand the number of candidate SNPs to several hundreds or more. The general methodology may be applied in many genetic/protein biomarker studies with limited patient data.
Supporting Information
Footnotes
Competing Interests: The authors have declared that no competing interests exist.
Funding: The research did not receive any external funding. This work was funded by an internal grant from Memorial Sloan-Kettering Cancer Center. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
References
- 1.Rieger KE, Hong WJ, Tusher VG, Tang J, Tibshirani R. Toxicity from radiation therapy associated with abnormal transcriptional responses to DNA damage. Proc Natl Acad Sci U S A. 2004;101:6640. doi: 10.1073/pnas.0307761101. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Jen KY, Cheung VG. Transcriptional response of lymphoblastoid cells to ionizing radiation. Genome Res. 2003;13:2100. doi: 10.1101/gr.1240103. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Rieger KE, Chu G. Portrait of transcriptional responses to ultraviolet and ionizing radiation in human cells. Nucleic Acids Res. 2004;32:4803. doi: 10.1093/nar/gkh783. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Eschrich S, Zhang H, Zhao H, Boulware D, Lee JH. Systems biology modeling of the radiation sensitivity network: a biomarker discovery platform. Int J Radiat Oncol Biol Phys. 2009;75:505. doi: 10.1016/j.ijrobp.2009.05.056. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Popanda O, Marquardt JU, Chang-Claude J, Schmezer P. Genetic variation in normal tissue toxicity induced by ionizing radiation. Mutat Res. 2009;667:69. doi: 10.1016/j.mrfmmm.2008.10.014. [DOI] [PubMed] [Google Scholar]
- 6.Andreassen CN, Alsner J. Genetic variants and normal tissue toxicity after radiotherapy: a systematic review. Radiother Oncol. 2009;92:309. doi: 10.1016/j.radonc.2009.06.015. [DOI] [PubMed] [Google Scholar]
- 7.Oh JH, Craft JM, Townsend R, Deasy JO, Bradley JD. A bioinformatics approach for biomarker identification in radiation-induced lung inflammation from limited proteomics data. J Proteome Res. 2011;10:1415. doi: 10.1021/pr101226q. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Templin T, Paul S, Amundson SA, Young EF, Barker CA. Radiation-induced micro-RNA expression changes in peripheral blood cells of radiotherapy patients. Int J Radiat Oncol Biol Phys. 2011;80:557. doi: 10.1016/j.ijrobp.2010.12.061. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Dexter TJ, Sims D, Mitsopoulos C, Mackay A, Grigoriadis A. Genomic distance entrained clustering and regression modelling highlights interacting genomic regions contributing to proliferation in breast cancer. BMC Syst Biol. 2010;4:127. doi: 10.1186/1752-0509-4-127. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Storey JD, Tibshirani R. Statistical significance for genomewide studies. Proc Natl Acad Sci U S A. 2003;100:9445. doi: 10.1073/pnas.1530509100. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Chen T, Guo L, Zhang L, Shi L, Fang H. Gene expression profiles distinguish the carcinogenic effects of aristolochic acid in target (kidney) and non-target (liver) tissues in rats. BMC Bioinformatics. 2006;7:S20. doi: 10.1186/1471-2105-7-S2-S20. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Larsson O, Wahlestedt C, Timmons JA. Considerations when using the significance analysis of microarrays (SAM) algorithm. BMC Bioinformatics. 2005;6:129. doi: 10.1186/1471-2105-6-129. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Brigl B, Strübing A, Wendt T, Winter A. Modeling interdependencies between information processes and communication paths in hospitals. Methods Inf Med. 2006;45:224. [PubMed] [Google Scholar]
- 14.Isomura M, Oya N, Tachiiri S, Kaneyasu Y, Nishimura Y. IL12RB2 and ABCA1 genes are associated with susceptibility to radiation dermatitis. Clin Cancer Res. 2008;14:6689. doi: 10.1158/1078-0432.CCR-07-4389. [DOI] [PubMed] [Google Scholar]
- 15.Chiani F, Iannone C, Negri R, Paoletti D, D'Antonio M. Radiation Genes: a database devoted to microarrays screenings revealing transcriptome alterations induced by ionizing radiation in mammalian cells. Database (Oxford) 2009;2009:bap007. doi: 10.1093/database/bap007. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Turtoi A, Schneeweiss FH. Effect of (211)At alpha-particle irradiation on expression of selected radiation responsive genes in human lymphocytes. Int J Radiat Biol. 2009;85:412. doi: 10.1080/09553000902838541. [DOI] [PubMed] [Google Scholar]
- 17.Valdagni R, Rancati T, Ghilotti M, Cozzarini C, Vavassori V. To bleed or not to bleed. A prediction based on individual gene profiling combined with dose-volume histogram shapes in prostate cancer patients undergoing three-dimensional conformal radiation therapy. Int J Radiat Oncol Biol Phys. 2009;74:1440. doi: 10.1016/j.ijrobp.2008.10.021. [DOI] [PubMed] [Google Scholar]
- 18.Toulany M, Kehlbach R, Florczak U, Sak A, Wang S. Targeting of AKT1 enhances radiation toxicity of human tumor cells by inhibiting DNA-PKcs-dependent DNA double-strand break repair. Mol Cancer Ther. 2008;7:1781. doi: 10.1158/1535-7163.MCT-07-2200. [DOI] [PubMed] [Google Scholar]
- 19.Suga T, Ishikawa A, Kohda M, Otsuka Y, Yamada S. Haplotype-based analysis of genes associated with risk of adverse skin reactions after radiotherapy in breast cancer patients. Int J Radiat Oncol Biol Phys. 2007;69:693. doi: 10.1016/j.ijrobp.2007.06.021. [DOI] [PubMed] [Google Scholar]
- 20.Suga T, Iwakawa M, Tsuji H, Ishikawa H, Oda E. Influence of multiple genetic polymorphisms on genitourinary morbidity after carbon ion radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys. 2008;72:813. doi: 10.1016/j.ijrobp.2008.01.029. [DOI] [PubMed] [Google Scholar]
- 21.Xu QY, Gao Y, Liu Y, Yang WZ, Xu XY. Identification of differential gene expression profiles of radioresistant lung cancer cell line established by fractionated ionizing radiation in vitro. Chin Med J (Engl) 2008;121:1837. [PubMed] [Google Scholar]
- 22.Chang-Claude J, Popanda O, Tan XL, Kropp S, Helmbold I. Association between polymorphisms in the DNA repair genes, XRCC1, APE1, and XPD and acute side effects of radiotherapy in breast cancer patients. Clin Cancer Res. 2005;11:4809. doi: 10.1158/1078-0432.CCR-04-2657. [DOI] [PubMed] [Google Scholar]
- 23.Sak SC, Harnden P, Johnston CF, Paul AB, Kiltie AE. APE1 and XRCC1 protein expression levels predict cancer-specific survival following radical radiotherapy in bladder cancer. Clin Cancer Res. 2005;11:6211. doi: 10.1158/1078-0432.CCR-05-0045. [DOI] [PubMed] [Google Scholar]
- 24.Xiang DB, Chen ZT, Wang D, Li MX, Xie JY. Chimeric adenoviral vector Ad5/F35-mediated APE1 siRNA enhances sensitivity of human colorectal cancer cells to radiotherapy in vitro and in vivo. Cancer Gene Ther. 2008;15:635. doi: 10.1038/cgt.2008.30. [DOI] [PubMed] [Google Scholar]
- 25.Andreassen CN, Alsner J, Overgaard M, Sørensen FB, Overgaard J. Risk of radiation-induced subcutaneous fibrosis in relation to single nucleotide polymorphisms in TGFB1, SOD2, XRCC1, XRCC3, APEX and ATM–a study based on DNA from formalin fixed paraffin embedded tissue samples. Int J Radiat Biol. 2006;82:586. doi: 10.1080/09553000600876637. [DOI] [PubMed] [Google Scholar]
- 26.Andreassen CN, Alsner J, Overgaard J, Herskind C, Haviland J. TGFB1 polymorphisms are associated with risk of late normal tissue complications in the breast after radiotherapy for early breast cancer. Radiother Oncol. 2005;75:21. doi: 10.1016/j.radonc.2004.12.012. [DOI] [PubMed] [Google Scholar]
- 27.Higuchi Y, Nelson GA, Vazquez M, Laskowitz DT, Slater JM. Apolipoprotein E expression and behavioral toxicity of high charge, high energy (HZE) particle radiation. J Radiat Res. 2002;43 doi: 10.1269/jrr.43.s219. [DOI] [PubMed] [Google Scholar]
- 28.Kool J, Hamdi M, Cornelissen-Steijger P, van der Eb AJ, Terleth C. Induction of ATF3 by ionizing radiation is mediated via a signaling pathway that includes ATM, Nibrin1, stress-induced MAPkinases and ATF-2. Oncogene. 2003;22:4242. doi: 10.1038/sj.onc.1206611. [DOI] [PubMed] [Google Scholar]
- 29.Borgmann K, Röper B, El-Awady R, Brackrock S, Bigalke M. Indicators of late normal tissue response after radiotherapy for head and neck cancer: fibroblasts, lymphocytes, genetics, DNA repair, and chromosome aberrations. Radiother Oncol. 2002;64:152. doi: 10.1016/s0167-8140(02)00167-6. [DOI] [PubMed] [Google Scholar]
- 30.Azria D, Ozsahin M, Kramar A, Peters S, Atencio DP. Single nucleotide polymorphisms, apoptosis, and the development of severe late adverse effects after radiotherapy. Clin Cancer Res. 2008;14:6288. doi: 10.1158/1078-0432.CCR-08-0700. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Moore J, Stock RG, Cesaretti JA, Stone NN, Li W. Single nucleotide polymorphisms as predictors for development of erectile dysfunction in African-American men treated with radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys. 2007;69:S7. doi: 10.1016/j.ijrobp.2010.07.036. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Appleby JM, Barber JB, Levine E, Varley JM, Taylor AM. Absence of mutations in the ATM gene in breast cancer patients with severe responses to radiotherapy. Br J Cancer. 1997;76:1549. doi: 10.1038/bjc.1997.593. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Iannuzzi CM, Atencio DP, Green S, Stock RG, Rosenstein BS. ATM mutations in female breast cancer patients predict for an increase in radiation-induced late effects. Int J Radiat Oncol Biol Phys. 2002;52:613. doi: 10.1016/s0360-3016(01)02684-0. [DOI] [PubMed] [Google Scholar]
- 34.Hall EJ, Schiff PB, Hanks GE, Brenner DJ, Russo J. A preliminary report: frequency of A-T heterozygotes among prostate cancer patients with severe late responses to radiation therapy. Cancer J Sci Am. 1998;4:389. [PubMed] [Google Scholar]
- 35.Pugh TJ, Keyes M, Barclay L, Delaney A, Krzywinski M. Sequence variant discovery in DNA repair genes from radiosensitive and radiotolerant prostate brachytherapy patients. Clin Cancer Res. 2009;15:5016. doi: 10.1158/1078-0432.CCR-08-3357. [DOI] [PubMed] [Google Scholar]
- 36.Zschenker O, Raabe A, Boeckelmann IK, Borstelmann S, Szymczak S. Association of single nucleotide polymorphisms in ATM, GSTP1, SOD2, TGFB1, XPD and XRCC1 with clinical and cellular radiosensitivity. Radiother Oncol. 2010;97:32. doi: 10.1016/j.radonc.2010.01.016. [DOI] [PubMed] [Google Scholar]
- 37.Hendry JH, Hoyes KP, Wadeson P, Roberts SA. Role of damage-sensing/processing genes in the radiation response of haemopoietic in vitro colony-forming cells. Int J Radiat Biol. 2002;78:566. doi: 10.1080/09553000210132333. [DOI] [PubMed] [Google Scholar]
- 38.Mao JH, Wu D, DelRosario R, Castellanos A, Balmain A. Atm heterozygosity does not increase tumor susceptibility to ionizing radiation alone or in a p53 heterozygous background. Oncogene. 2008;27:6600. doi: 10.1038/onc.2008.280. [DOI] [PubMed] [Google Scholar]
- 39.Worgul BV, Smilenov L, Brenner DJ, Junk A, Zhou W. Atm heterozygous mice are more sensitive to radiation-induced cataracts than are their wild-type counterparts. Proc Natl Acad Sci U S A. 2002;99:9839. doi: 10.1073/pnas.162349699. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Clarke RA, Fang ZH, Marr PJ, Lee CS, Kearsley JH. ATM induction insufficiency in a radiosensitive breast-cancer patient. Australas Radiol. 2002;46:335. doi: 10.1046/j.1440-1673.2002.01072.x. [DOI] [PubMed] [Google Scholar]
- 41.Mirzayans R, Severin D, Murray D. Relationship between DNA double-strand break rejoining and cell survival after exposure to ionizing radiation in human fibroblast strains with differing ATM/p53 status: implications for evaluation of clinical radiosensitivity. Int J Radiat Oncol Biol Phys. 2006;66:1505. doi: 10.1016/j.ijrobp.2006.08.064. [DOI] [PubMed] [Google Scholar]
- 42.Paterson MC, Anderson AK, Smith BP, Smith PJ. Enhanced radiosensitivity of cultured fibroblasts from ataxia telangiectasia heterozygotes manifested by defective colony-forming ability and reduced DNA repair replication after hypoxic gamma-irradiation. Cancer Res. 1979;39:3734. [PubMed] [Google Scholar]
- 43.Fernet M, Hall J. Genetic biomarkers of therapeutic radiation sensitivity. DNA Repair (Amst) 2004;3:1243. doi: 10.1016/j.dnarep.2004.03.019. [DOI] [PubMed] [Google Scholar]
- 44.Chorna IV, Datsyuk LO, Stoika RS. Expression of Bax, Bad and Bcl-2 proteins under x-radiation effect towards human breast carcinoma MCF-7 cells and their doxorubicin-resistant derivatives. Exp Oncol. 2005;27:201. [PubMed] [Google Scholar]
- 45.Moretti L, Attia A, Kim KW, Lu B. Crosstalk between Bak/Bax and mTOR signaling regulates radiation-induced autophagy. Autophagy. 2007;3:144. doi: 10.4161/auto.3607. [DOI] [PubMed] [Google Scholar]
- 46.Haffty BG, Glazer PM. Molecular markers in clinical radiation oncology. Oncogene. 2003;22:5925. doi: 10.1038/sj.onc.1206704. [DOI] [PubMed] [Google Scholar]
- 47.Burns TF, Bernhard EJ, El-Deiry WS. Tissue specific expression of p53 target genes suggests a key role for KILLER/DR5 in p53-dependent apoptosis in vivo. Oncogene. 2001;20:4612. doi: 10.1038/sj.onc.1204484. [DOI] [PubMed] [Google Scholar]
- 48.Badie C, Dziwura S, Raffy C, Tsigani T, Alsbeih G. Aberrant CDKN1A transcriptional response associates with abnormal sensitivity to radiation treatment. Br J Cancer. 2008;98:1851. doi: 10.1038/sj.bjc.6604381. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Kabacik S, Mackay A, Tamber N, Manning G, Finnon P. Gene expression following ionising radiation: identification of biomarkers for dose estimation and prediction of individual response. Int J Radiat Biol. 2011;87:129. doi: 10.3109/09553002.2010.519424. [DOI] [PubMed] [Google Scholar]
- 50.Paul S, Amundson SA. Development of gene expression signatures for practical radiation biodosimetry. Int J Radiat Oncol Biol Phys. 2008;71:1244. doi: 10.1016/j.ijrobp.2008.03.043. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51.Kim DW, Seo SW, Cho SK, Chang SS, Lee HW. Targeting of cell survival genes using small interfering RNAs (siRNAs) enhances radiosensitivity of Grade II chondrosarcoma cells. J Orthop Res. 2007;25:828. doi: 10.1002/jor.20377. [DOI] [PubMed] [Google Scholar]
- 52.Guo WF, Lin RX, Huang J, Zhou Z, Yang J. Identification of differentially expressed genes contributing to radioresistance in lung cancer cells using microarray analysis. Radiat Res. 2005;164:35. doi: 10.1667/rr3401. [DOI] [PubMed] [Google Scholar]
- 53.Guan HT, Xue XH, Dai ZJ, Wang XJ, Li A. Down-regulation of survivin expression by small interfering RNA induces pancreatic cancer cell apoptosis and enhances its radiosensitivity. World J Gastroenterol. 2006;12:2907. doi: 10.3748/wjg.v12.i18.2901. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54.Gaffney DK, Brohet RM, Lewis CM, Holden JA, Buys SS. Response to radiation therapy and prognosis in breast cancer patients with BRCA1 and BRCA2 mutations. Radiother Oncol. 1998;47:136. doi: 10.1016/s0167-8140(98)00023-1. [DOI] [PubMed] [Google Scholar]
- 55.Shanley S, McReynolds K, Ardern-Jones A, Ahern R, Fernando I. Late toxicity is not increased in BRCA1/BRCA2 mutation carriers undergoing breast radiotherapy in the United Kingdom. Clin Cancer Res. 2006;12:7032. doi: 10.1158/1078-0432.CCR-06-1244. [DOI] [PubMed] [Google Scholar]
- 56.Pierce LJ, Strawderman M, Narod SA, Oliviotto I, Eisen A. Effect of radiotherapy after breast-conserving treatment in women with breast cancer and germline BRCA1/2 mutations. J Clin Oncol. 2000;18:3369. doi: 10.1200/JCO.2000.18.19.3360. [DOI] [PubMed] [Google Scholar]
- 57.Leong T, Whitty J, Keilar M, Mifsud S, Ramsay J. Mutation analysis of BRCA1 and BRCA2 cancer predisposition genes in radiation hypersensitive cancer patients. Int J Radiat Oncol Biol Phys. 2000;48:965. doi: 10.1016/s0360-3016(00)00728-8. [DOI] [PubMed] [Google Scholar]
- 58.Abbott DW, Thompson ME, Robinson-Benion C, Tomlinson G, Jensen RA. BRCA1 expression restores radiation resistance in BRCA1-defective cancer cells through enhancement of transcription-coupled DNA repair. J Biol Chem. 1999;274:18812. doi: 10.1074/jbc.274.26.18808. [DOI] [PubMed] [Google Scholar]
- 59.Ernestos B, Nikolaos P, Koulis G, Eleni R, Konstantinos B. Increased chromosomal radiosensitivity in women carrying BRCA1/BRCA2 mutations assessed with the G2 assay. Int J Radiat Oncol Biol Phys. 2010;76:1205. doi: 10.1016/j.ijrobp.2009.10.020. [DOI] [PubMed] [Google Scholar]
- 60.Higgins GS, Prevo R, Lee YF, Helleday T, Muschel RJ. A small interfering RNA screen of genes involved in DNA repair identifies tumor-specific radiosensitization by POLQ knockdown. Cancer Res. 2010;70:2993. doi: 10.1158/0008-5472.CAN-09-4040. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 61.Zhou T, Chou JW, Simpson DA, Zhou Y, Mullen TE. Profiles of global gene expression in ionizing-radiation-damaged human diploid fibroblasts reveal synchronization behind the G1 checkpoint in a G0-like state of quiescence. Environ Health Perspect. 2006;114:559. doi: 10.1289/ehp.8026. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 62.Kuptsova N, Chang-Claude J, Kropp S, Helmbold I, Schmezer P. Genetic predictors of long-term toxicities after radiation therapy for breast cancer. Int J Cancer. 2008;122:1339. doi: 10.1002/ijc.23138. [DOI] [PubMed] [Google Scholar]
- 63.Hehlgans S, Eke I, Storch K, Haase M, Baretton GB. Caveolin-1 mediated radioresistance of 3D grown pancreatic cancer cells. Radiother Oncol. 2009;92:370. doi: 10.1016/j.radonc.2009.07.004. [DOI] [PubMed] [Google Scholar]
- 64.Hixon JA, Blazar BR, Anver MR, Wiltrout RH, Murphy WJ. Antibodies to CD40 induce a lethal cytokine cascade after syngeneic bone marrow transplantation. Biol Blood Marrow Transplant. 2001;7:143. doi: 10.1053/bbmt.2001.v7.pm11302547. [DOI] [PubMed] [Google Scholar]
- 65.Wischhusen J, Jung G, Radovanovic I, Beier C, Steinbach JP. Identification of CD70-mediated apoptosis of immune effector cells as a novel immune escape pathway of human glioblastoma. Cancer Res. 2002;62:2599. [PubMed] [Google Scholar]
- 66.Taniguchi K, Momiyama N, Ueda M, Matsuyama R, Mori R. Targeting of CDC20 via small interfering RNA causes enhancement of the cytotoxicity of chemoradiation. Anticancer Res. 2008;28:1563. [PubMed] [Google Scholar]
- 67.Snyder AR, Morgan WF. Gene expression profiling after irradiation: clues to understanding acute and persistent responses? Cancer Metastasis Rev. 2004;23:268. doi: 10.1023/B:CANC.0000031765.17886.fa. [DOI] [PubMed] [Google Scholar]
- 68.Correa CR, Cheung VG. Genetic variation in radiation-induced expression phenotypes. Am J Hum Genet. 2004;75:890. doi: 10.1086/425221. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 69.Moussavi-Harami F, Mollano A, Martin JA, Ayoob A, Domann FE. Intrinsic radiation resistance in human chondrosarcoma cells. Biochem Biophys Res Commun. 2006;346:385. doi: 10.1016/j.bbrc.2006.05.158. [DOI] [PubMed] [Google Scholar]
- 70.Lu HR, Wang X, Wang Y. A stronger DNA damage-induced G2 checkpoint due to over-activated CHK1 in the absence of PARP-1. Cell Cycle. 2006;5:2370. doi: 10.4161/cc.5.20.3355. [DOI] [PubMed] [Google Scholar]
- 71.Xiao Z, Xue J, Sowin TJ, Rosenberg SH, Zhang H. A novel mechanism of checkpoint abrogation conferred by Chk1 downregulation. Oncogene. 2005;24:1411. doi: 10.1038/sj.onc.1208309. [DOI] [PubMed] [Google Scholar]
- 72.Kim JS, Chang JW, Yun HS, Yang KM, Hong EH. Chloride intracellular channel 1 identified using proteomic analysis plays an important role in the radiosensitivity of HEp-2 cells via reactive oxygen species production. Proteomics. 2010;10:2604. doi: 10.1002/pmic.200900523. [DOI] [PubMed] [Google Scholar]
- 73.Liu L, Zou JJ, Luo HS, Wu DH. [Effect of protein kinase CK2 gene silencing on radiosensitization in human nasopharyngeal carcinoma cells]. Nan Fang Yi Ke Da Xue Xue Bao. 2009;29:1553. [PubMed] [Google Scholar]
- 74.Damaraju S, Murray D, Dufour J, Carandang D, Myrehaug S. Association of DNA repair and steroid metabolism gene polymorphisms with clinical late toxicity in patients treated with conformal radiotherapy for prostate cancer. Clin Cancer Res. 2006;12:2554. doi: 10.1158/1078-0432.CCR-05-2703. [DOI] [PubMed] [Google Scholar]
- 75.Kim KW, Moretti L, Mitchell LR, Jung DK, Lu B. Endoplasmic reticulum stress mediates radiation-induced autophagy by perk-eIF2alpha in caspase-3/7-deficient cells. Oncogene. 2010;29:3251. doi: 10.1038/onc.2010.74. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 76.Shi HS, Ren DL, Cao XM, Huang L, Jiang Y. [Small interfering RNA targeting C-erbB-2 gene increases the radiosensitivity of lung adenocarcinoma cells in vitro]. Nan Fang Yi Ke Da Xue Xue Bao. 2008;28:1980. [PubMed] [Google Scholar]
- 77.Pietras RJ, Poen JC, Gallardo D, Wongvipat PN, Lee HJ. Monoclonal antibody to HER-2/neureceptor modulates repair of radiation-induced DNA damage and enhances radiosensitivity of human breast cancer cells overexpressing this oncogene. Cancer Res. 1999;59:1355. [PubMed] [Google Scholar]
- 78.Xu W, Debeb BG, Lacerda L, Woodward WA. Potential targets for improving radiosensitivity of breast tumor-initiating cells. Anticancer Agents Med Chem. 2010;10:156. doi: 10.2174/187152010790909362. [DOI] [PubMed] [Google Scholar]
- 79.Kornguth DG, Garden AS, Zheng Y, Dahlstrom KR, Wei Q. Gastrostomy in oropharyngeal cancer patients with ERCC4 (XPF) germline variants. Int J Radiat Oncol Biol Phys. 2005;62:671. doi: 10.1016/j.ijrobp.2004.11.026. [DOI] [PubMed] [Google Scholar]
- 80.Reap EA, Roof K, Maynor K, Borrero M, Booker J. Radiation and stress-induced apoptosis: a role for Fas/Fas ligand interactions. Proc Natl Acad Sci U S A. 1997;94:5755. doi: 10.1073/pnas.94.11.5750. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 81.Peña LA, Fuks Z, Kolesnick RN. Radiation-induced apoptosis of endothelial cells in the murine central nervous system: protection by fibroblast growth factor and sphingomyelinase deficiency. Cancer Res. 2000;60:327. [PubMed] [Google Scholar]
- 82.Chang JT, Chan SH, Lin CY, Lin TY, Wang HM. Differentially expressed genes in radioresistant nasopharyngeal cancer cells: gp96 and GDF15. Mol Cancer Ther. 2007;6:2279. doi: 10.1158/1535-7163.MCT-06-0801. [DOI] [PubMed] [Google Scholar]
- 83.Cao Y, Fu YL, Yu M, Yue PB, Ge CH. Human augmenter of liver regeneration is important for hepatoma cell viability and resistance to radiation-induced oxidative stress. Free Radic Biol Med. 2009;47:1066. doi: 10.1016/j.freeradbiomed.2009.07.017. [DOI] [PubMed] [Google Scholar]
- 84.Barahmani N, Carpentieri S, Li XN, Wang T, Cao Y. Glutathione S-transferase M1 and T1 polymorphisms may predict adverse effects after therapy in children with medulloblastoma. Neuro Oncol. 2009;11:300. doi: 10.1215/15228517-2008-089. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 85.Edvardsen H, Kristensen VN, Grenaker Alnaes GI, Bøhn M, Erikstein B. Germline glutathione S-transferase variants in breast cancer: relation to diagnosis and cutaneous long-term adverse effects after two fractionation patterns of radiotherapy. Int J Radiat Oncol Biol Phys. 2007;67:1171. doi: 10.1016/j.ijrobp.2006.11.009. [DOI] [PubMed] [Google Scholar]
- 86.Ambrosone CB, Tian C, Ahn J, Kropp S, Helmbold I. Genetic predictors of acute toxicities related to radiation therapy following lumpectomy for breast cancer: a case-series study. Breast Cancer Res. 2006;8:R40. doi: 10.1186/bcr1526. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 87.Munshi A, Kurland JF, Nishikawa T, Tanaka T, Hobbs ML. Histone deacetylase inhibitors radiosensitize human melanoma cells by suppressing DNA repair activity. Clin Cancer Res. 2005;11:4922. doi: 10.1158/1078-0432.CCR-04-2088. [DOI] [PubMed] [Google Scholar]
- 88.Yoshida K, Morita T. Control of radiosensitivity of F9 mouse teratocarcinoma cells by regulation of histone H2AX gene expression using a tetracycline turn-off system. Cancer Res. 2004;64:4136. doi: 10.1158/0008-5472.CAN-03-2566. [DOI] [PubMed] [Google Scholar]
- 89.Zhang B, Wang Y, Pang X. Enhanced radiosensitivity of EC109 cells by inhibition of HDAC1 expression. Med Oncol. 2010. [DOI] [PubMed]
- 90.Bekker-Jensen S, Rendtlew Danielsen J, Fugger K, Gromova I, Nerstedt A. HERC2 coordinates ubiquitin-dependent assembly of DNA repair factors on damaged chromosomes. Nat Cell Biol 12: 80–86; sup 81–12. 2010. [DOI] [PubMed]
- 91.Kassem HSh, Sangar V, Cowan R, Clarke N, Margison GP. A potential role of heat shock proteins and nicotinamide N-methyl transferase in predicting response to radiation in bladder cancer. Int J Cancer. 2002;101:460. doi: 10.1002/ijc.10631. [DOI] [PubMed] [Google Scholar]
- 92.Hadchity E, Aloy MT, Paulin C, Armandy E, Watkin E. Heat shock protein 27 as a new therapeutic target for radiation sensitization of head and neck squamous cell carcinoma. Mol Ther. 2009;17:1394. doi: 10.1038/mt.2009.90. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 93.Wang X, Hu B, Weiss RS, Wang Y. The effect of Hus1 on ionizing radiation sensitivity is associated with homologous recombination repair but is independent of nonhomologous end-joining. Oncogene. 2006;25:1983. doi: 10.1038/sj.onc.1209212. [DOI] [PubMed] [Google Scholar]
- 94.Ishigami T, Uzawa K, Fushimi K, Saito K, Kato Y. Inhibition of ICAM2 induces radiosensitization in oral squamous cell carcinoma cells. Br J Cancer. 2008;98:1365. doi: 10.1038/sj.bjc.6604290. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 95.Ding KK, Shang ZF, Hao C, Xu QZ, Shen JJ. Induced expression of the IER5 gene by gamma-ray irradiation and its involvement in cell cycle checkpoint control and survival. Radiat Environ Biophys. 2009;48:213. doi: 10.1007/s00411-009-0213-4. [DOI] [PubMed] [Google Scholar]
- 96.Yavari K, Taghikhani M, Maragheh MG, Mesbah-Namin SA, Babaei MH. SiRNA-mediated IGF-1R inhibition sensitizes human colon cancer SW480 cells to radiation. Acta Oncol. 2010;49:75. doi: 10.3109/02841860903334429. [DOI] [PubMed] [Google Scholar]
- 97.Tan W, Huang W, Zhong Q, Schwarzenberger P. IL-17 receptor knockout mice have enhanced myelotoxicity and impaired hemopoietic recovery following gamma irradiation. J Immunol. 2006;176:6193. doi: 10.4049/jimmunol.176.10.6186. [DOI] [PubMed] [Google Scholar]
- 98.Eke I, Leonhardt F, Storch K, Hehlgans S, Cordes N. The small molecule inhibitor QLT0267 Radiosensitizes squamous cell carcinoma cells of the head and neck. PLoS One. 2009;4:e6434. doi: 10.1371/journal.pone.0006434. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 99.Brunner TB, Cengel KA, Hahn SM, Wu J, Fraker DL. Pancreatic cancer cell radiation survival and prenyltransferase inhibition: the role of K-Ras. Cancer Res. 2005;65:8441. doi: 10.1158/0008-5472.CAN-05-0158. [DOI] [PubMed] [Google Scholar]
- 100.Riballo E, Doherty AJ, Dai Y, Stiff T, Oettinger MA. Cellular and biochemical impact of a mutation in DNA ligase IV conferring clinical radiosensitivity. J Biol Chem. 2001;276:31132. doi: 10.1074/jbc.M103866200. [DOI] [PubMed] [Google Scholar]
- 101.Fogarty GB, Muddle R, Sprung CN, Chen W, Duffy D. Unexpectedly severe acute radiotherapy side effects are associated with single nucleotide polymorphisms of the melanocortin-1 receptor. Int J Radiat Oncol Biol Phys. 2010;77:1492. doi: 10.1016/j.ijrobp.2009.07.1690. [DOI] [PubMed] [Google Scholar]
- 102.Guoan X, Hanning W, Kaiyun C, Hao L. Adenovirus-mediated siRNA targeting Mcl-1 gene increases radiosensitivity of pancreatic carcinoma cells in vitro and in vivo. Surgery. 2010;147:561. doi: 10.1016/j.surg.2009.10.033. [DOI] [PubMed] [Google Scholar]
- 103.Guo W, Ahmed KM, Hui Y, Guo G, Li JJ. siRNA-mediated MDM2 inhibition sensitizes human lung cancer A549 cells to radiation. Int J Oncol. 2007;30:1452. [PubMed] [Google Scholar]
- 104.Chetty C, Bhoopathi P, Rao JS, Lakka SS. Inhibition of matrix metalloproteinase-2 enhances radiosensitivity by abrogating radiation-induced FoxM1-mediated G2/M arrest in A549 lung cancer cells. Int J Cancer. 2009;124:2477. doi: 10.1002/ijc.24209. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 105.Ahn GO, Brown JM. Matrix metalloproteinase-9 is required for tumor vasculogenesis but not for angiogenesis: role of bone marrow-derived myelomonocytic cells. Cancer Cell. 2008;13:205. doi: 10.1016/j.ccr.2007.11.032. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 106.Ahn J, Ambrosone CB, Kanetsky PA, Tian C, Lehman TA. Polymorphisms in genes related to oxidative stress (CAT, MnSOD, MPO, and eNOS) and acute toxicities from radiation therapy following lumpectomy for breast cancer. Clin Cancer Res. 2006;12:7070. doi: 10.1158/1078-0432.CCR-06-0039. [DOI] [PubMed] [Google Scholar]
- 107.Cecchin E, Agostini M, Pucciarelli S, De Paoli A, Canzonieri V. Tumor response is predicted by patient genetic profile in rectal cancer patients treated with neo-adjuvant chemo-radiotherapy. Pharmacogenomics J. 2011;11:226. doi: 10.1038/tpj.2010.25. [DOI] [PubMed] [Google Scholar]
- 108.Sheen JH, Dickson RB. Overexpression of c-Myc alters G(1)/S arrest following ionizing radiation. Mol Cell Biol. 2002;22:1833. doi: 10.1128/MCB.22.6.1819-1833.2002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 109.Popanda O, Tan XL, Ambrosone CB, Kropp S, Helmbold I. Genetic polymorphisms in the DNA double-strand break repair genes XRCC3, XRCC2, and NBS1 are not associated with acute side effects of radiotherapy in breast cancer patients. Cancer Epidemiol Biomarkers Prev. 2006;15:1050. doi: 10.1158/1055-9965.EPI-06-0046. [DOI] [PubMed] [Google Scholar]
- 110.Das A, Boldogh I, Lee JW, Harrigan JA, Hegde ML. The human Werner syndrome protein stimulates repair of oxidative DNA base damage by the DNA glycosylase NEIL1. J Biol Chem. 2007;282:26602. doi: 10.1074/jbc.M703343200. [DOI] [PubMed] [Google Scholar]
- 111.Mi J, Guo C, Brautigan DL, Larner JM. Protein phosphatase-1alpha regulates centrosome splitting through Nek2. Cancer Res. 2007;67:1089. doi: 10.1158/0008-5472.CAN-06-3071. [DOI] [PubMed] [Google Scholar]
- 112.Wang Y, Meng A, Lang H, Brown SA, Konopa JL. Activation of nuclear factor kappaB In vivo selectively protects the murine small intestine against ionizing radiation-induced damage. Cancer Res. 2004;64:6246. doi: 10.1158/0008-5472.CAN-04-0591. [DOI] [PubMed] [Google Scholar]
- 113.Li S, Kuhne WW, Kulharya A, Hudson FZ, Ha K. Involvement of p54(nrb), a PSF partner protein, in DNA double-strand break repair and radioresistance. Nucleic Acids Res. 2009;37:6753. doi: 10.1093/nar/gkp741. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 114.Park S, Ahn JY, Lim MJ, Kim MH, Yun YS. Sustained expression of NADPH oxidase 4 by p38 MAPK-Akt signaling potentiates radiation-induced differentiation of lung fibroblasts. J Mol Med (Berl) 2010;88:816. doi: 10.1007/s00109-010-0622-5. [DOI] [PubMed] [Google Scholar]
- 115.Sterpone S, Cornetta T, Padua L, Mastellone V, Giammarino D. DNA repair capacity and acute radiotherapy adverse effects in Italian breast cancer patients. Mutat Res. 2010;684:48. doi: 10.1016/j.mrfmmm.2009.11.009. [DOI] [PubMed] [Google Scholar]
- 116.Zhang B, Wang Y, Liu K, Yang X, Song M. Adenovirus-mediated transfer of siRNA against peroxiredoxin I enhances the radiosensitivity of human intestinal cancer. Biochem Pharmacol. 2008;75:667. doi: 10.1016/j.bcp.2007.09.016. [DOI] [PubMed] [Google Scholar]
- 117.Fernet M, Ponette V, Deniaud-Alexandre E, Ménissier-De Murcia J, De Murcia G. Poly(ADP-ribose) polymerase, a major determinant of early cell response to ionizing radiation. Int J Radiat Biol. 2000;76:1629. doi: 10.1080/09553000050201118. [DOI] [PubMed] [Google Scholar]
- 118.Shan B, Xu J, Zhuo Y, Morris CA, Morris GF. Induction of p53-dependent activation of the human proliferating cell nuclear antigen gene in chromatin by ionizing radiation. J Biol Chem. 2003;278:44017. doi: 10.1074/jbc.M302671200. [DOI] [PubMed] [Google Scholar]
- 119.Hamilton J, Grawenda AM, Bernhard EJ. Phosphatase inhibition and cell survival after DNA damage induced by radiation. Cancer Biol Ther. 2009;8:1586. doi: 10.4161/cbt.8.16.8962. [DOI] [PubMed] [Google Scholar]
- 120.Prevo R, Deutsch E, Sampson O, Diplexcito J, Cengel K. Class I PI3 kinase inhibition by the pyridinylfuranopyrimidine inhibitor PI-103 enhances tumor radiosensitivity. Cancer Res. 2008;68:5923. doi: 10.1158/0008-5472.CAN-08-0757. [DOI] [PubMed] [Google Scholar]
- 121.Vens C, Dahmen-Mooren E, Verwijs-Janssen M, Blyweert W, Graversen L. The role of DNA polymerase beta in determining sensitivity to ionizing radiation in human tumor cells. Nucleic Acids Res. 2002;30:3004. doi: 10.1093/nar/gkf403. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 122.Rossi M, Demidov ON, Anderson CW, Appella E, Mazur SJ. Induction of PPM1D following DNA-damaging treatments through a conserved p53 response element coincides with a shift in the use of transcription initiation sites. Nucleic Acids Res. 2008;36:7180. doi: 10.1093/nar/gkn888. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 123.Park JJ, Chang HW, Jeong EJ, Roh JL, Choi SH. Peroxiredoxin IV protects cells from radiation-induced apoptosis in head-and-neck squamous cell carcinoma. Int J Radiat Oncol Biol Phys. 2009;73:1202. doi: 10.1016/j.ijrobp.2008.10.070. [DOI] [PubMed] [Google Scholar]
- 124.Abbaszadeh F, Clingen PH, Arlett CF, Plowman PN, Bourton EC. A novel splice variant of the DNA-PKcs gene is associated with clinical and cellular radiosensitivity in a patient with xeroderma pigmentosum. J Med Genet. 2010;47:181. doi: 10.1136/jmg.2009.068866. [DOI] [PubMed] [Google Scholar]
- 125.Peng Y, Zhang Q, Nagasawa H, Okayasu R, Liber HL. Silencing expression of the catalytic subunit of DNA-dependent protein kinase by small interfering RNA sensitizes human cells for radiation-induced chromosome damage, cell killing, and mutation. Cancer Res. 2002;62:6404. [PubMed] [Google Scholar]
- 126.Ogawa K, Boucher Y, Kashiwagi S, Fukumura D, Chen D. Influence of tumor cell and stroma sensitivity on tumor response to radiation. Cancer Res. 2007;67:4021. doi: 10.1158/0008-5472.CAN-06-4498. [DOI] [PubMed] [Google Scholar]
- 127.Chiou SH, Kao CL, Chen YW, Chien CS, Hung SC. Identification of CD133-positive radioresistant cells in atypical teratoid/rhabdoid tumor. PLoS One. 2008;3:e2090. doi: 10.1371/journal.pone.0002090. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 128.Pazzaglia S, Tanori M, Mancuso M, Rebessi S, Leonardi S. Linking DNA damage to medulloblastoma tumorigenesis in patched heterozygous knockout mice. Oncogene. 2006;25:1173. doi: 10.1038/sj.onc.1209032. [DOI] [PubMed] [Google Scholar]
- 129.Lee C, Kim JS, Waldman T. PTEN gene targeting reveals a radiation-induced size checkpoint in human cancer cells. Cancer Res. 2004;64:6914. doi: 10.1158/0008-5472.CAN-04-1767. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 130.Chen WS, Yu YC, Lee YJ, Chen JH, Hsu HY. Depletion of securin induces senescence after irradiation and enhances radiosensitivity in human cancer cells regardless of functional p53 expression. Int J Radiat Oncol Biol Phys. 2010;77:574. doi: 10.1016/j.ijrobp.2009.12.013. [DOI] [PubMed] [Google Scholar]
- 131.Severin DM, Leong T, Cassidy B, Elsaleh H, Peters L. Novel DNA sequence variants in the hHR21 DNA repair gene in radiosensitive cancer patients. Int J Radiat Oncol Biol Phys. 2001;50:1331. doi: 10.1016/s0360-3016(01)01608-x. [DOI] [PubMed] [Google Scholar]
- 132.Djuzenova C, Mühl B, Schakowski R, Oppitz U, Flentje M. Normal expression of DNA repair proteins, hMre11, Rad50 and Rad51 but protracted formation of Rad50 containing foci in X-irradiated skin fibroblasts from radiosensitive cancer patients. Br J Cancer. 2004;90:2363. doi: 10.1038/sj.bjc.6601878. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 133.Welsh JW, Ellsworth RK, Kumar R, Fjerstad K, Martinez J. Rad51 protein expression and survival in patients with glioblastoma multiforme. Int J Radiat Oncol Biol Phys. 2009;74:1255. doi: 10.1016/j.ijrobp.2009.03.018. [DOI] [PubMed] [Google Scholar]
- 134.Raaphorst GP, Leblanc M, Li LF. A comparison of response to cisplatin, radiation and combined treatment for cells deficient in recombination repair pathways. Anticancer Res. 2005;25:58. [PubMed] [Google Scholar]
- 135.Singhal SS, Roth C, Leake K, Singhal J, Yadav S. Regression of prostate cancer xenografts by RLIP76 depletion. Biochem Pharmacol. 2009;77:1083. doi: 10.1016/j.bcp.2008.11.013. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 136.Singhal SS, Sehrawat A, Sahu M, Singhal P, Vatsyayan R. Rlip76 transports sunitinib and sorafenib and mediates drug resistance in kidney cancer. Int J Cancer. 2010;126:1338. doi: 10.1002/ijc.24767. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 137.Kuo ML, Hwang HS, Sosnay PR, Kunugi KA, Kinsella TJ. Overexpression of the R2 subunit of ribonucleotide reductase in human nasopharyngeal cancer cells reduces radiosensitivity. Cancer J. 2003;9:285. doi: 10.1097/00130404-200307000-00010. [DOI] [PubMed] [Google Scholar]
- 138.Yokomakura N, Natsugoe S, Okumura H, Ikeda R, Uchikado Y. Improvement in radiosensitivity using small interfering RNA targeting p53R2 in esophageal squamous cell carcinoma. Oncol Rep. 2007;18:567. [PubMed] [Google Scholar]
- 139.Jia L, Yang J, Hao X, Zheng M, He H. Validation of SAG/RBX2/ROC2 E3 ubiquitin ligase as an anticancer and radiosensitizing target. Clin Cancer Res. 2010;16:824. doi: 10.1158/1078-0432.CCR-09-1592. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 140.Chung HJ, Yoon SI, Shin SH, Koh YA, Lee SJ. p53-Mediated enhancement of radiosensitivity by selenophosphate synthetase 1 overexpression. J Cell Physiol. 2006;209:141. doi: 10.1002/jcp.20714. [DOI] [PubMed] [Google Scholar]
- 141.Milliat F, Sabourin JC, Tarlet G, Holler V, Deutsch E. Essential role of plasminogen activator inhibitor type-1 in radiation enteropathy. Am J Pathol. 2008;172:701. doi: 10.2353/ajpath.2008.070930. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 142.Chang CJ, Hsu CC, Yung MC, Chen KY, Tzao C. Enhanced radiosensitivity and radiation-induced apoptosis in glioma CD133-positive cells by knockdown of SirT1 expression. Biochem Biophys Res Commun. 2009;380:242. doi: 10.1016/j.bbrc.2009.01.040. [DOI] [PubMed] [Google Scholar]
- 143.Peter Y, Rotman G, Lotem J, Elson A, Shiloh Y. Elevated Cu/Zn-SOD exacerbates radiation sensitivity and hematopoietic abnormalities of Atm-deficient mice. EMBO J. 2001;20:1546. doi: 10.1093/emboj/20.7.1538. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 144.Burri RJ, Stock RG, Cesaretti JA, Atencio DP, Peters S. Association of single nucleotide polymorphisms in SOD2, XRCC1 and XRCC3 with susceptibility for the development of adverse effects resulting from radiotherapy for prostate cancer. Radiat Res. 2008;170:59. doi: 10.1667/RR1219.1. [DOI] [PubMed] [Google Scholar]
- 145.Andreassen CN, Alsner J, Overgaard M, Overgaard J. Prediction of normal tissue radiosensitivity from polymorphisms in candidate genes. Radiother Oncol. 2003;69:135. doi: 10.1016/j.radonc.2003.09.010. [DOI] [PubMed] [Google Scholar]
- 146.Dittmann K, Mayer C, Kehlbach R, Rodemann HP. Radiation-induced caveolin-1 associated EGFR internalization is linked with nuclear EGFR transport and activation of DNA-PK. Mol Cancer. 2008;7:69. doi: 10.1186/1476-4598-7-69. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 147.Hui Z, Tretiakova M, Zhang Z, Li Y, Wang X. Radiosensitization by inhibiting STAT1 in renal cell carcinoma. Int J Radiat Oncol Biol Phys. 2009;73:295. doi: 10.1016/j.ijrobp.2008.08.043. [DOI] [PubMed] [Google Scholar]
- 148.Bonner JA, Trummell HQ, Willey CD, Plants BA, Raisch KP. Inhibition of STAT-3 results in radiosensitization of human squamous cell carcinoma. Radiother Oncol. 2009;92:344. doi: 10.1016/j.radonc.2009.06.022. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 149.Li X, Wang H, Lu X, Di B. STAT3 blockade with shRNA enhances radiosensitivity in Hep-2 human laryngeal squamous carcinoma cells. Oncol Rep. 2010;23:353. [PubMed] [Google Scholar]
- 150.Giotopoulos G, Symonds RP, Foweraker K, Griffin M, Peat I. The late radiotherapy normal tissue injury phenotypes of telangiectasia, fibrosis and atrophy in breast cancer patients have distinct genotype-dependent causes. Br J Cancer. 2007;96:1007. doi: 10.1038/sj.bjc.6603637. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 151.Meyer A, Dörk T, Bogdanova N, Brinkhaus MJ, Wiese B. TGFB1 gene polymorphism Leu10Pro (c.29T>C), prostate cancer incidence and quality of life in patients treated with brachytherapy. World J Urol. 2009;27:377. doi: 10.1007/s00345-008-0354-0. [DOI] [PubMed] [Google Scholar]
- 152.Yuan X, Liao Z, Liu Z, Wang LE, Tucker SL. Single nucleotide polymorphism at rs1982073:T869C of the TGFbeta 1 gene is associated with the risk of radiation pneumonitis in patients with non-small-cell lung cancer treated with definitive radiotherapy. J Clin Oncol. 2009;27:3378. doi: 10.1200/JCO.2008.20.6763. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 153.Kim dR, Laurence B, Jan VM, Wilfried dN, Hubert T. Association of TGFbeta1 polymorphisms involved in radiation toxicity with TGFbeta1 secretion in vitro. Cytokine. 2010;50:41. doi: 10.1016/j.cyto.2009.12.013. [DOI] [PubMed] [Google Scholar]
- 154.Alsbeih G, Al-Harbi N, Al-Hadyan K, El-Sebaie M, Al-Rajhi N. Association between normal tissue complications after radiotherapy and polymorphic variations in TGFB1 and XRCC1 genes. Radiat Res. 2010;173:511. doi: 10.1667/RR1769.1. [DOI] [PubMed] [Google Scholar]
- 155.Zhang M, Qian J, Xing X, Kong FM, Zhao L. Inhibition of the tumor necrosis factor-alpha pathway is radioprotective for the lung. Clin Cancer Res. 2008;14:1876. doi: 10.1158/1078-0432.CCR-07-1894. [DOI] [PubMed] [Google Scholar]
- 156.Shankar S, Singh TR, Chen X, Thakkar H, Firnin J. The sequential treatment with ionizing radiation followed by TRAIL/Apo-2L reduces tumor growth and induces apoptosis of breast tumor xenografts in nude mice. Int J Oncol. 2004;24:1140. [PubMed] [Google Scholar]
- 157.Jiao Y, Ge CM, Meng QH, Cao JP, Tong J. Adenovirus-mediated expression of Tob1 sensitizes breast cancer cells to ionizing radiation. Acta Pharmacol Sin. 2007;28:1636. doi: 10.1111/j.1745-7254.2007.00647.x. [DOI] [PubMed] [Google Scholar]
- 158.Terry SY, Riches AC, Bryant PE. Suppression of topoisomerase IIalpha expression and function in human cells decreases chromosomal radiosensitivity. Mutat Res. 2009;663:45. doi: 10.1016/j.mrfmmm.2009.01.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 159.Thurfjell N, Coates PJ, Vojtesek B, Benham-Motlagh P, Eisold M. Endogenous p63 acts as a survival factor for tumour cells of SCCHN origin. Int J Mol Med. 2005;16:1070. [PubMed] [Google Scholar]
- 160.Firat E, Tsurumi C, Gaedicke S, Huai J, Niedermann G. Tripeptidyl peptidase II plays a role in the radiation response of selected primary cell types but not based on nuclear translocation and p53 stabilization. Cancer Res. 2009;69:3331. doi: 10.1158/0008-5472.CAN-08-3269. [DOI] [PubMed] [Google Scholar]
- 161.Zheng M, Morgan-Lappe SE, Yang J, Bockbrader KM, Pamarthy D. Growth inhibition and radiosensitization of glioblastoma and lung cancer cells by small interfering RNA silencing of tumor necrosis factor receptor-associated factor 2. Cancer Res. 2008;68:7578. doi: 10.1158/0008-5472.CAN-08-0632. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 162.Demizu Y, Sasaki R, Trachootham D, Pelicano H, Colacino JA. Alterations of cellular redox state during NNK-induced malignant transformation and resistance to radiation. Antioxid Redox Signal. 2008;10:961. doi: 10.1089/ars.2007.1871. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 163.Javvadi P, Hertan L, Kosoff R, Datta T, Kolev J. Thioredoxin reductase-1 mediates curcumin-induced radiosensitization of squamous carcinoma cells. Cancer Res. 2010;70:1950. doi: 10.1158/0008-5472.CAN-09-3025. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 164.Li XL, Meng QH, Fan SJ. Adenovirus-mediated expression of UHRF1 reduces the radiosensitivity of cervical cancer HeLa cells to gamma-irradiation. Acta Pharmacol Sin. 2009;30:466. doi: 10.1038/aps.2009.18. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 165.Yan J, Kim YS, Yang XP, Li LP, Liao G. The ubiquitin-interacting motif containing protein RAP80 interacts with BRCA1 and functions in DNA damage repair response. Cancer Res. 2007;67:6656. doi: 10.1158/0008-5472.CAN-07-0924. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 166.Langsenlehner T, Kapp KS, Langsenlehner U. TGFB1 single-nucleotide polymorphisms are associated with adverse quality of life in prostate cancer patients treated with radiotherapy. In regard to Peters, et al. (Int J Radiat Oncol Biol Phys 2008;70: 752–759). Int J Radiat Oncol Biol Phys 71: 960; author reply 960–961. 2008. [DOI] [PubMed]
- 167.Clark AJ, Chan DC, Chen MY, Fillmore H, Dos Santos WG. Down-regulation of Wilms' tumor 1 expression in glioblastoma cells increases radiosensitivity independently of p53. J Neurooncol. 2007;83:172. doi: 10.1007/s11060-006-9317-8. [DOI] [PubMed] [Google Scholar]
- 168.Giagkousiklidis S, Vellanki SH, Debatin KM, Fulda S. Sensitization of pancreatic carcinoma cells for gamma-irradiation-induced apoptosis by XIAP inhibition. Oncogene. 2007;26:7016. doi: 10.1038/sj.onc.1210502. [DOI] [PubMed] [Google Scholar]
- 169.Wang R, Li B, Wang X, Lin F, Gao P. Inhibiting XIAP expression by RNAi to inhibit proliferation and enhance radiosensitivity in laryngeal cancer cell line. Auris Nasus Larynx. 2009;36:339. doi: 10.1016/j.anl.2008.08.006. [DOI] [PubMed] [Google Scholar]
- 170.Wiebalk K, Schmezer P, Kropp S, Chang-Claude J, Celebi O. In vitro radiation-induced expression of XPC mRNA as a possible biomarker for developing adverse reactions during radiotherapy. Int J Cancer. 2007;121:2345. doi: 10.1002/ijc.22981. [DOI] [PubMed] [Google Scholar]
- 171.Moullan N, Cox DG, Angèle S, Romestaing P, Gérard JP. Polymorphisms in the DNA repair gene XRCC1, breast cancer risk, and response to radiotherapy. Cancer Epidemiol Biomarkers Prev. 2003;12:1174. [PubMed] [Google Scholar]
- 172.De Ruyck K, Wilding CS, Van Eijkeren M, Morthier R, Tawn EJ. Microsatellite polymorphisms in DNA repair genes XRCC1, XRCC3 and XRCC5 in patients with gynecological tumors: association with late clinical radiosensitivity and cancer incidence. Radiat Res. 2005;164:244. doi: 10.1667/rr3417.1. [DOI] [PubMed] [Google Scholar]
- 173.Brem R, Cox DG, Chapot B, Moullan N, Romestaing P. The XRCC1–77T->C variant: haplotypes, breast cancer risk, response to radiotherapy and the cellular response to DNA damage. Carcinogenesis. 2006;27:2474. doi: 10.1093/carcin/bgl114. [DOI] [PubMed] [Google Scholar]
- 174.Price EA, Bourne SL, Radbourne R, Lawton PA, Lamerdin J. Rare microsatellite polymorphisms in the DNA repair genes XRCC1, XRCC3 and XRCC5 associated with cancer in patients of varying radiosensitivity. Somat Cell Mol Genet. 1997;23:247. doi: 10.1007/BF02674415. [DOI] [PubMed] [Google Scholar]
- 175.De Ruyck K, Van Eijkeren M, Claes K, Morthier R, De Paepe A. Radiation-induced damage to normal tissues after radiotherapy in patients treated for gynecologic tumors: association with single nucleotide polymorphisms in XRCC1, XRCC3, and OGG1 genes and in vitro chromosomal radiosensitivity in lymphocytes. Int J Radiat Oncol Biol Phys. 2005;62:1149. doi: 10.1016/j.ijrobp.2004.12.027. [DOI] [PubMed] [Google Scholar]
- 176.Werbrouck J, De Ruyck K, Duprez F, Veldeman L, Claes K. Acute normal tissue reactions in head-and-neck cancer patients treated with IMRT: influence of dose and association with genetic polymorphisms in DNA DSB repair genes. Int J Radiat Oncol Biol Phys. 2009;73:1195. doi: 10.1016/j.ijrobp.2008.08.073. [DOI] [PubMed] [Google Scholar]
- 177.Wachsberger PR, Li WH, Guo M, Chen D, Cheong N. Rejoining of DNA double-strand breaks in Ku80-deficient mouse fibroblasts. Radiat Res. 1999;151:407. [PubMed] [Google Scholar]
- 178.Vandersickel V, Mancini M, Slabbert J, Marras E, Thierens H. The radiosensitizing effect of Ku70/80 knockdown in MCF10A cells irradiated with X-rays and p(66)+Be(40) neutrons. Radiat Oncol. 2010;5:30. doi: 10.1186/1748-717X-5-30. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 179.Negroni A, Stronati L, Grollino MG, Barattini P, Gumiero D. Radioresistance in a tumour cell line correlates with radiation inducible Ku 70/80 end-binding activity. Int J Radiat Biol. 2008;84:276. doi: 10.1080/09553000801953318. [DOI] [PubMed] [Google Scholar]
- 180.Vandersickel V, Mancini M, Marras E, Willems P, Slabbert J. Lentivirus-mediated RNA interference of Ku70 to enhance radiosensitivity of human mammary epithelial cells. Int J Radiat Biol. 2010;86:124. doi: 10.3109/09553000903419940. [DOI] [PubMed] [Google Scholar]
- 181.Urano M, He F, Minami A, Ling CC, Li GC. Response to multiple radiation doses of human colorectal carcinoma cells infected with recombinant adenovirus containing dominant-negative Ku70 fragment. Int J Radiat Oncol Biol Phys. 2010;77:885. doi: 10.1016/j.ijrobp.2009.12.062. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 182.Sakata K, Someya M, Matsumoto Y, Hareyama M. Ability to repair DNA double-strand breaks related to cancer susceptibility and radiosensitivity. Radiat Med. 2007;25:438. doi: 10.1007/s11604-007-0161-3. [DOI] [PubMed] [Google Scholar]
- 183.Du XL, Jiang T, Wen ZQ, Gao R, Cui M. Silencing of heat shock protein 70 expression enhances radiotherapy efficacy and inhibits cell invasion in endometrial cancer cell line. Croat Med J. 2009;50:150. doi: 10.3325/cmj.2009.50.143. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 184.O'Malley BW, Li D, Carney J, Rhee J, Suntharalingam M. Molecular disruption of the MRN(95) complex induces radiation sensitivity in head and neck cancer. Laryngoscope. 2003;113:1594. doi: 10.1097/00005537-200309000-00034. [DOI] [PubMed] [Google Scholar]
- 185.Cengel KA, McKenna WG. Molecular targets for altering radiosensitivity: lessons from Ras as a pre-clinical and clinical model. Crit Rev Oncol Hematol. 2005;55:116. doi: 10.1016/j.critrevonc.2005.02.001. [DOI] [PubMed] [Google Scholar]
- 186.Pawlik TM, Keyomarsi K. Role of cell cycle in mediating sensitivity to radiotherapy. Int J Radiat Oncol Biol Phys. 2004;59:942. doi: 10.1016/j.ijrobp.2004.03.005. [DOI] [PubMed] [Google Scholar]
- 187.Tusher VG, Tibshirani R, Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci U S A. 2001;98:5121. doi: 10.1073/pnas.091062498. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 188.Merbl Y, Kirschner MW. Large-scale detection of ubiquitination substrates using cell extracts and protein microarrays. Proc Natl Acad Sci U S A. 2009;106:2548. doi: 10.1073/pnas.0812892106. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 189.Moussay E, Palissot V, Vallar L, Poirel HA, Wenner T. Determination of genes and microRNAs involved in the resistance to fludarabine in vivo in chronic lymphocytic leukemia. Mol Cancer. 2010;9:115. doi: 10.1186/1476-4598-9-115. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 190.Blalock EM, Chen KC, Stromberg AJ, Norris CM, Kadish I. Harnessing the power of gene microarrays for the study of brain aging and Alzheimer's disease: statistical reliability and functional correlation. Ageing Res Rev. 2005;4:512. doi: 10.1016/j.arr.2005.06.006. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.